Evidence map›Paper›PMID 39437780›Full record

ArticleCell2024

P-stalk ribosomes act as master regulators of cytokine-mediated processes.

Anna Dopler, Ferhat Alkan, Yuval Malka, Rob van der Kammen, Kelly Hoefakker, Daniel Taranto, Naz Kocabay, Iris Mimpen, Christel Ramirez, Elke Malzer and 12 more

Abstract read
In one paragraph

Article in Cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Function ofOncology letters · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. Ribosome-associated proteins: unwRAPping ribosome heterogeneity in the twenty-first century.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  17. Ribosome heterogeneity and specialization.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Anna DoplerDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Ferhat AlkanDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Yuval MalkaDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Rob van der KammenDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Kelly HoefakkerDivision of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Daniel TarantoDivision of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Naz KocabayDivision of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Iris MimpenDivision of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Christel RamirezDivision of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Elke MalzerDivision of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Olga I IsaevaDivision of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Mandy KerkhoffDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Anastasia GangaevDivision of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Joana SilvaDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Sofia RamalhoDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Liesbeth HoekmanProteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Maarten AltelaarProteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Roderick BeijersbergenDivision of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Leila AkkariDivision of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Jonathan Wilson YewdellCellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Pia KvistborgDivision of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
William James FallerDivision of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: w.faller@nki.nl.

Funding

Delivery Of Antigens To The MHC Class I Processing PathwayZIAAI000653 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI YEWDELL, JONATHAN W · 2009 to 2015
$2.8M
Intramural NIH HHS ZIA AI000653
6 · The paper itself

Abstract

Inflammatory cytokines are pivotal to immune responses. Upon cytokine exposure, cells enter an "alert state" that enhances their visibility to the immune system. Here, we identified an alert-state subpopulation of ribosomes defined by the presence of the P-stalk. We show that P-stalk ribosomes (PSRs) are formed in response to cytokines linked to tumor immunity, and this is at least partially mediated by P-stalk phosphorylation. PSRs are involved in the preferential translation of mRNAs vital for the cytokine response via the more efficient translation of transmembrane domains of receptor molecules involved in cytokine-mediated processes. Importantly, loss of the PSR inhibits CD8+ T cell recognition and killing, and inhibitory cytokines like transforming growth factor β (TGF-β) hinder PSR formation, suggesting that the PSR is a central regulatory hub upon which multiple signals converge. Thus, the PSR is an essential mediator of the cellular rewiring that occurs following cytokine exposure via the translational regulation of this process.

Indexed as

CD8-Positive T-LymphocytesCytokinesProtein BiosynthesisRibosomesAnimalsHumansMiceMice, Inbred C57BLPhosphorylationRNA, MessengerSignal TransductionTransforming Growth Factor betaCytokinesRNA, MessengerTransforming Growth Factor betacytokinesmelanomaP-stalkribosomeT cells

Identifiers

PMID39437780
PMCPMC11896023

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.